November 14, 2022 from 7:00 am – 8:15 am EST
Spondyloarthritis (SpA) is a group of progressive, inflammatory diseases that includes axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA), as well as other peripheral types of SpA. These diseases share a number of typical clinical features such as inflammatory back pain, peripheral arthritis, enthesitis, and dactylitis, as well as extra-articular features such as uveitis, psoriasis, and inflammatory bowel disease. In addition, they can profoundly impact patient quality of life, causing functional disability and loss of work productivity. Recently, there have been a number of developments in SpA, including an increased understanding of pathogenesis, improved awareness of SpA, and new, efficacious therapies. This virtual symposium will feature a “test and teach” style presentation in which expert faculty will challenge one another on their clinical decision-making while encouraging the audience to consider their own approach. Case presentations will be leveraged to test learners’ knowledge/competence in managing complex cases of spondyloarthritis followed by expert instruction and rationale that teaches evidence-based management strategies.
Speakers:
Joseph Merola MD, MMSc
Harvard Medical School Associate Professor
Boston, Massachusetts
Vice Chair of Clinical Trials and Innovation Director, Center for Skin and Related Musculoskeletal Diseases Director, Clinical Unit for Research Innovation and Trials Department of Dermatology and Department of Medicine Division of Rheumatology Brigham and Women’s Hospital Boston, Massachusetts
Abhijeet Danve MD, MHS, FACP
Yale School of Medicine
Assistant Professor of Medicine
New Haven, Connecticut
Director, Yale Spondyloarthritis Program Co-chair, Rheumatology Quality and Safety Council
Philip Mease MD
University of Washington School of Medicine
Clinical Professor
Seattle, Washington
Director of Rheumatology Research Swedish Medical Center Providence-St. Joseph Health Seattle, Washington